key: cord-0692572-uv8aes88 authors: Monto, Arnold S. title: Viral respiratory infections in the community: Epidemiology, agents, and interventions date: 1995-12-29 journal: The American Journal of Medicine DOI: 10.1016/s0002-9343(99)80307-6 sha: bcacb10cf4f14b3837a2632f269da025bc8dd0f8 doc_id: 692572 cord_uid: uv8aes88 Viral respiratory infections are a leading cause of acute morbidity in the community. The annual frequency of respiratory illness rises during the second year of life, falls during subsequent years, increases again during child-bearing years, then decreases with advancing age (although some increase may be seen in the elderly). In terms of restriction on activity and prompting of visits to physicians, the greatest number of illnesses are associated with rhinoviruses followed by influenza viruses. However, comparing rhinovirus and influenza, there is no doubt that influenza viruses produce more severe symptoms. In some years, when there is a major influenza outbreak, they may even be identified at greater frequency. Moreover, unlike with other viruses, severity of influenza infection is high at all ages, but especially in older individuals. Influenza vaccine, which has been available for half a century, has proved effective in preventing hospitalizations for pneumonia and influenza during outbreaks of influenza types A and B. The antiviral agents amantadine and rimantadine provide approximately equivalent, and significant, efficacy in protection against clinical illness resulting from influenza type A only. However, the potential for side effects is more marked with amantadine. Some studies have shown that the rate of treatment withdrawal is no greater with rimantadine than with placebo. As we enter the next century, we may well see improvements in influenza vaccines, as well as the advent of antiviral agents that are effective against both type A and type B influenza. years, increases again during child-bearing years, then decreases with advancing age (although some increase may be seen in the elderly). In terms of restriction on activity and prompting of visits to physicians, the greatest number of illnesses are associated with rhinoviruses followed by influenza viruses. However, comparing rhinovirus and influenza, there is no doubt that influenza viruses produce more severe symptoms. In some years, when there is a major influenza outbreak, they may even be identified at greater frequency. Moreover, unlike with other viruses, severity of influenza infection is high at all ages, but especially in older individuals. Influenza vaccine, which has been available for half a century, has proved effective in preventing hospitalizations for pneumonia and influenza during outbreaks of influenza types A and B. The antiviral agents amantadine and rimantadine provide approximately equivalent, and signillcant, efficacy in protection against clinical illness resulting from influenza type A only. However, the potential for side effects is more marked with amantadine. Some studies have shown that the rate of treatment withdrawal is no greater with rimantadine than with placebo. As we enter the next century, we may well see improvements in influenza vaccines, as well as the advent of antiviral agents that are effective against both type A and type B influenza. Children <6 months old are relatively spared from community-based respiratory infections. The annual frequency of respiratory illness rises during the second year of life, then falls ( Figure 11 .' The frequency increases again during the child-bearing years as parents are exposed to children in the age groups that have the greatest burden of respiratory illnesses. Apart from the mere presence of children in the family, the age of the oldest child is correlated with the occurrence of illnesses ( Figure 2 ).2 This pattern reflects the important role of children in the introduction and transmission of illness. As adults advance in age, the frequency of respiratory illness decreases, although several series have shown some increase among individuals in their late 60s and 70s ( Figure 1 ). Table I summarizes the etiologic agents of greatest concern with regard to respiratory illness in the community. Because lower respiratory illnesses in community-based studies are difficult to identify based on clinical characteristics, alternative indices of severity must be used. Our group has used activity restriction, the number of physician consultations, and other data, such as frequency of illness and days off work as reported in telephone interviews to measure ranges of disease burden. These are shown as a scale from 0 to >4 of increasing severity in Table I . Reinfection with the same agent is a major feature of nearly all these viruses. While reinfection may not produce clinical disease, it does have consequences in terms of transmission of illness to others. Respiratory syncytial virus is notorious for producing bronchiolitis and pneumonia in young children, but also frequently causes reinfection (either asymptomatic infection or mild respiratory illness) in older individuals. A similar pattern is evident 66-24s December 29, 1995 The American Journal of Medicine Volume 99 kuppl 6B) with parainfluenza viruses. Approximately 40% of children